Complete lymphadenectomy following positive sentinel lymph node biopsy in cutaneous melanoma: a critical review

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

(2017) Mark B. Faries et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma

(2017) Georgina V. Long et al.   NEW ENGLAND JOURNAL OF MEDICINE

Completion Lymph Node Dissection or Observation for Melanoma Sentinel Lymph Node Metastases: A Decision Analysis

(2016) Erin E. Burke et al.   ANNALS OF SURGICAL ONCOLOGY

SPECT/CT Improves Detection of Metastatic Sentinel Lymph Nodes in Patients with Head and Neck Melanoma

(2016) Brandon C. Chapman et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients

(2016) Hongying Hao et al.   ANNALS OF SURGICAL ONCOLOGY

Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients

(2016) T. Gambichler et al.   EJSO

Fluorescence guided surgery and tracer-dose, fact or fiction?

(2016) Gijs H. KleinJan et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Weighing the value of completion nodal dissection for melanoma

(2016) Jason B. Liu et al.   JOURNAL OF SURGICAL ONCOLOGY

Sentinel lymph node biopsy plus wide local excision vs. wide location excision alone for primary cutaneous melanoma: a systematic review and meta-analysis

(2016) J. Santos-Juanes et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology

(2016) Daniel G. Coit et al.   Journal of the National Comprehensive Cancer Network

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

(2016) Ulrike Leiter et al.   LANCET ONCOLOGY

Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma

(2015) David Y. Lee et al.   ANNALS OF SURGICAL ONCOLOGY

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

(2015) Alexander M M Eggermont et al.   LANCET ONCOLOGY

Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

(2014) Donald L. Morton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis

(2013) V. Nagaraja et al.   EJSO

Analysis of regional recurrence after negative sentinel lymph node biopsy for head and neck melanoma

(2012) Kelly McDonald et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria

(2011) Augustinus P.T. van der Ploeg et al.   JOURNAL OF CLINICAL ONCOLOGY

Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients

(2010) Charles R. Scoggins et al.   ANNALS OF SURGICAL ONCOLOGY

Comparison of classification systems in melanoma sentinel lymph nodes-An analysis of 697 patients from a single center

(2010) Andre Meier et al.   CANCER

Non-Sentinel Node Risk Score (N-SNORE): A Scoring System for Accurately Stratifying Risk of Non-Sentinel Node Positivity in Patients With Cutaneous Melanoma With Positive Sentinel Lymph Nodes

(2010) Rajmohan Murali et al.   JOURNAL OF CLINICAL ONCOLOGY

Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

(2010) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel Node Status Prediction by Four Statistical Models

(2009) Simone Mocellin et al.   ANNALS OF SURGERY

Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients

(2009) Y. Socrier et al.   BRITISH JOURNAL OF DERMATOLOGY

Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients

(2008) Alexander C. J. van Akkooi et al.   ANNALS OF SURGERY

False-positive cells in sentinel lymph nodes

(2008) Jeoffry B. Brennick et al.   SEMINARS IN DIAGNOSTIC PATHOLOGY